Zacks: Crawford & Company (CRD.B) Given $13.00 Average Price Target by Brokerages

Crawford & Company (NYSE:CRD.B) has been assigned a consensus broker rating score of 1.33 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and two have given a strong buy rating to the company.

Brokerages have set a 1 year consensus price target of $13.00 for the company and are forecasting that the company will post $0.18 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Crawford & Company an industry rank of 104 out of 265 based on the ratings given to its competitors.

A number of research firms have weighed in on CRD.B. ValuEngine downgraded Crawford & Company from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research raised Crawford & Company from a “hold” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Wednesday, January 24th.

Crawford & Company (NYSE:CRD.B) opened at $8.97 on Thursday. Crawford & Company has a 12-month low of $8.22 and a 12-month high of $12.40. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.68 and a current ratio of 1.68. The firm has a market capitalization of $500.22, a P/E ratio of 11.96 and a beta of 1.79.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at

Crawford & Company Company Profile

Crawford & Company (Crawford) is an independent provider of claims management solutions to insurance and self-insured entities. The Company’s Crawford Solution offers claims services, business process outsourcing and consulting services for various product lines, including property and casualty claims management; workers’ compensation claims and medical management, and legal settlement administration.

Get a free copy of the Zacks research report on Crawford & Company (CRD.B)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Crawford & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crawford & Company and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply